Browse By: Country ι Category ι Publisher ι Tag

Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2013 Edition

Pages » 208
Published By » JustPharmaReports.com
Price » $2350
In stock
View Report Details
Description

The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only hope. But is this enough to assure premium prices and special status in an era of budget limitations, and growing demands for evidence of clinical and cost effectiveness? Payers are becoming increasingly strict. Four of the first seven orphan drugs to enter Germany’s AMNOG procedure were considered to bring only minor additional benefit and for two others the benefit was deemed non-quantifiable.... Click here for more details


Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2011 Edition
The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only h
Published Date: Jun 2011
Price: $2300
Market Access Korea: Breaking into the Developed World\'s Fastest Growing Pharmaceutical Market
South Korea as a country has been an economic success story and the origin of much cutting edge technology, but its pharmaceutical market can now also be given ‘Asian tiger’ status. The past four years have seen total sales growth of 15.6%, 13.5%, 12.4% and 13.8% respectively. IMS
Published Date: Nov 2010
Price: $1380
Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access
A major new report Orphan Drugs in Asia-Pacific: From designation to pricing, funding and market access focuses on five developed markets in the region: Japan, South Korea, Taiwan, Singapore and Australia. Each has passed specific measures to promote the development, registration and/or commer
Published Date: Feb 2010
Price: $2320
Biosimilars: Current Situation & Future Prospects, Worldwide
The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in the global biologics market expected to lose some degree of protection by 2019. All major countr
Published Date: Mar 2012
Price: $3000
Pharmaceutical Pricing & Distribution in Japan, 2010 Update
The author’s 2008 major title ‘Pharmaceutical Pricing & Distribution in Japan’ was described by PhRMA Japan as ‘a superb report…to understand Japan there is nothing better’. His new report packs all the essentials needed to optimise market access and life
Published Date: Oct 2011
Price: $760
Pharmaceutical Pricing & Distribution in Japan, 2012 Update
No serious pharmaceutical company can afford to ignore Japan, a $120 billion market, the second-largest in the world. It remains a tough and highly competitive market to crack, however, with the environment for developing and marketing medicines dominated by price.  No new bran
Published Date: Jun 2012
Price: $1400
Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide
Managed entry agreements apply to an increasing number of new, innovative drugs in a growing number of markets. They are designed to share the risk between the manufacturer and the payer, consequent on uncertainties - usually at launch - about the product’s value (clinical- and cost-effect
Published Date: Feb 2013
Price: $1050
Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2013 Edition
The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only hope. B
Published Date: Oct 2013
Price: $2350

 


 

Related News

Brent Crude Oil Prices Rise Above $97 after China: reports PMI
Brent crude experienced a rise of $97 per barrel on Tuesday. This was after a factory in China unexpectedly soared in terms of demand outlook in the global market in September.  The expectations proposed by the analysts for a reading of 50 about Brunt crude oil were beat from 50.2 in August to 50.5 in September as orders continued to rise, reported the HSBC China Purchasing Managers’ Index (PMI).  For November, Brent was up 15 cents by 0646 GMT reaching a value $97.12 per b
Date: Sep 25

Nova Chemicals Corp. Official Shipper for UTOPIA Project
Kinder Morgan Energy Partners recently announced the receiving of its transportation agreement with Nova Chemicals Corp. Nova Chemicals Corp. is headquartered in Alberta, Canada; however holds its operations in Moon Township. The company will receive ethane-propane and ethane mixtures from end to end Utica to Ontario Pipeline Access (UTOPIA) project.  Although more capacity is available within this project, through this deal, the project can advance to higher levels.  Currently,
Date: Sep 30

Innovation Center Established by PepsiCo in Dubai
The world’s food and beverage giant, PepsiCo has recently declared its plan of establishing an innovation center in the life sciences cluster DuBioTech situated in Dubai. This will be PepsiCo’s very first facility in this region. According to PepsiCo, the main rationale of this innovation facility will be to identify and cater to the preferences and tastes of the consumers in the local market. Furthermore, it also aims at promoting innovation in the regional market. In order to en
Date: Sep 30

Bendgate: iPhone 6 Plus Video May Have Been Fake
The YouTube video showing how the new iPhone 6 Plus could be bent out of shape may possibly be a fake. The claim about a ‘bendy’ iPhone 6 Plus went viral across the Internet, earning the name ‘Bendgate’. The video apparently spread panic among Apple users and customers, with them fearing that the smartphone may bend in their trouser pockets. Online forums and social media were abuzz with reactions, with #BendGate trending on Twitter.  Apple Inc. finally broke i
Date: Sep 29

Europeans Accept Chinese Electronics
A research conducted by the consultancy GfK revealed that European markets have grown to be more accepting of Chinese electronics and home appliance brands. The Chinese names have been expanding into European markets recently. The report states the overseas presence of Chinese home appliances and electronics market is increasing and now possesses a matured industry chain and rising shares. Their share will increase considerably once Chinese brands improve quality and performance. Chinese s
Date: Sep 25

News of Hyundai Motor’s Land Bid Sparks Strikes, Makes Wage Talks Complicated
General Motors Co. has announced its plans about opening headquarters of its Cadillac brand in New York next year, as a part of its strategy to expanding the brand’s appeal and remaking its image outside North America. Cadillac’s spokesman David Caldwell stated that the brand’s office, including event space and display, will open in the trendy Manhattan neighborhood Soho. The office is expected to be set up by the second quarter of 2015.  GM has stated that the move
Date: Sep 24

Delphi Takes Over Antaya
Delphi Automotive plc has recently signed an agreement that lets it control Antaya Technologies Corp. Antaya is a leader in providing proprietary on-glass connectors. The move improves Delphi’s portfolio and make it more feasible in the rapidly growing electrical connectors in automotives business. Antaya holds the leading position in the manufacture of on-glass connectors for the North American automotive glass industry. It has a growing customer base in China and Europe. Antaya also p
Date: Sep 23

Indian Regulatory Experts Push for Stronger Pharma Data Integrity
Regulatory experts in India have expressly stated their opinions on adding a special focus on tailing all the data integrity requirements. They are saying that this has to be done to avoid crackdown by regulatory agencies. The warning follows a growing number of letters issued by the US FDA and other international regulatory bodies to the Indian pharmaceutical companies regarding their poor data integrity. Inspectors have discovered major errors in the Indian files. Many firms like Sun Pharma
Date: Sep 22

China’s Huawei to Setup 4G Network in Cambodia
EMAXX, the Cambodian telecommunications company has signed a deal with the Chinese Huawei on Wednesday to build and develop a 4G network in Cambodia. The contract was signed by Ai Minn, the CEO of EMAXX, and the DGM of Huawei Technologies Weng Kefeng. The signing was performed in the presence of the Chinese Embassy’s Cambodian political councilor Li Zhigong and Kan Channmeta, Secretary of State at the Cambodian Ministry of Posts and Telecom. The contract states that Huawei will build
Date: Sep 18

Cost Watchdog of Britain’s Healthcare Sector Approves GSK’s Melanoma Drug under Price-Cut Conditions
Cost control agency of Britain’s healthcare sector, The National Institute for Health and Care Excellence (NICE), has recommended a drug for melanoma marketed by GlaxoSmithKline after the drug maker offered to supply it at a discounted rate to the National Health Service.  The drug, titled Tafinlar, is currently marketed by GSK but it will soon be transferred to Novartis under a trade deal between the tow companies.  Tafinlar is an oral drug that works in a way similar to R
Date: Sep 18

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency Market Research
Price: $4795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency Market Research
Price: $4795